Orthofix names Massimo Calafiore as President and CEO; Burzić not standing for re-election

Orthofix Medical Inc.

Massimo Calafiore appointed President and CEO effective early 2024, following LimaCorporate's acquisition by Enovis.
Calafiore receives $825k base salary, 110% target bonus, and $7.5M in equity inducement awards (50% performance RSUs, 25% options, 25% time RSUs).
He will receive a $225k after-tax relocation payment to San Diego area.
Interim CEO Catherine Burzić will not stand for re-election at 2024 Annual Meeting; remains Chair until then.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Massimo Calafiore

President and Chief Executive Officer

OFIX · Orthofix Medical Inc.

Filed: December 1, 2023, 6:59 PM ET

announced that Massimo Calafiore and the Company have agreed that Mr. Calafiore will become the Company’s President and Chief Executive Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Massimo Calafiore was appointed as President and Chief Executive Officer at Orthofix Medical Inc..

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

announced that Massimo Calafiore and the Company have agreed that Mr. Calafiore will become the Company’s President and Chief Executive Officer.

View on SEC.gov

Orthofix Medical Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-067364

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.